Abstract
We describe the case of an 82-year-old man who underwent 68 Ga-prostate-specific membrane antigen-11 (68 Ga-PSMA-11) positron emission tomography/computed tomography (PET/CT) for the restaging of prostate carcinoma. 68 Ga-PSMA-11 PET/CT unexpectedly showed increased tracer uptake homogenously involving the axial and appendicular bone marrow and the spleen, not characteristic for metastatic prostate disease. Further investigations revealed that 2 months before the patient underwent bone marrow biopsy, which showed the occurrence of monolinear myelodysplasia.
Data Availability
Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
References
Hofman MS, Hicks RJ, Maurer T, Eiber M. Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls. Radiographics. 2018;38:200–17.
Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3:81–5.
Chang SS, O’Keefe DS, Bacich DJ, Reuter VE, Heston WD, Gaudin PB. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res. 1999;5:2674–81.
Aguayo A, Giles F, Albitar M. Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes. Leuk Lymphoma. 2003;44:213–22.
Acksteiner C, Sounness B. Incidental finding of acute lymphocytic leukemia in a prostate-specific membrane antigen PET/CT. Clin Nucl Med. 2019;44:e529–31.
Arslan İ, Demirci E, Özkara S, Taşdelen N, Alan SN. Myelodysplastic syndrome presenting with diffuse bone marrow uptake on 68Ga-PSMA PET/CT. Clin Nucl Med. 2020;45:330–3.
Author information
Authors and Affiliations
Contributions
Conceptualization: M.B., M.I.D. Writing the original draft preparation: M.I.D. Revision of the original draft: M.B., S.M., S.R. Supervision: M.B.. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Conflict of Interests
Silvia Morbelli received speaker honoraria from General Electric and Eli-Lilly. Maria Isabella Donegani, Stefano Raffa, Alberto Miceli and Matteo Bauckneht declare they have no conflict of interests.
Ethics Approval and Consent to Participate
All procedures performed involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individuals.
Consent for Publication
The patient provided written informed consent for the publication of this case.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Donegani, M.I., Raffa, S., Miceli, A. et al. Increased 68 Ga-PSMA-11 Bone Marrow and Splenic Uptake in a Case of Erythroid Myelodysplasia. Nucl Med Mol Imaging 55, 323–324 (2021). https://doi.org/10.1007/s13139-021-00718-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-021-00718-2